Homocysteine Impairs Endothelial Cell Barrier Function and Angiogenic Potential via the Progranulin/EphA2 Pathway

• Egile Nagusiak: Dan Tian (Egilea), Qing Qin (Egilea), Mingfei Li (Egilea), Xiaoyu Li (Egilea), Qing Xu (Egilea), Qianzhou Lv (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2021-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Hyperhomocysteinemia is a well-recognized independent risk factor for cardiovascular disease. To date, the mechanism of pathological plasma homocysteine (Hcy) level elevation remains to be elucidated. We aimed to investigate the levels of progranulin (PGRN), Eph-receptor tyrosine kinase-type A2 (Eph...